A Collection of Articles


FDA Clears First Embryonic-Stem-Cell Therapy Trials

This video illustrates Geron’s, a California based cell therapy company, embryonic stem cell therapy for spinal cord injury in rats. The company has received clearance from the US FDA to begin clinical trials.

Uh oh–you've read all five of your free articles for this month.

Insider basic

$29.95/yr US PRICE

What's Included
  • 1 year (6 issues) of MIT Technology Review magazine in print OR digital format
  • Access to the entire online story archive: 1997-present
  • Special discounts to select partners
  • Discounts to our events

You've read of free articles this month.